These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3242655)
21. Antilymphocyte antibodies against CD4+2H4+ cell populations in patients with systemic lupus erythematosus. Tanaka S; Matsuyama T; Steinberg AD; Schlossman SF; Morimoto C Arthritis Rheum; 1989 Apr; 32(4):398-405. PubMed ID: 2523219 [TBL] [Abstract][Full Text] [Related]
22. Neuropsychological patterns in systemic lupus erythematosus patients with depression. Kozora E; Arciniegas DB; Zhang L; West S Arthritis Res Ther; 2007; 9(3):R48. PubMed ID: 17504538 [TBL] [Abstract][Full Text] [Related]
23. Neuropsychiatric systemic lupus erythematosus: diagnostic and clinical features according to revised ACR criteria. Buća A; Perković D; Martinović-Kaliterna D; Vlastelica M; Titlić M Coll Antropol; 2009 Mar; 33(1):281-8. PubMed ID: 19408638 [TBL] [Abstract][Full Text] [Related]
24. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome]. Ampélas JF; Wattiaux MJ; Van Amerongen AP Encephale; 2001; 27(6):588-99. PubMed ID: 11865567 [TBL] [Abstract][Full Text] [Related]
25. Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus. Massardo L; Bravo-Zehnder M; Calderón J; Flores P; Padilla O; Aguirre JM; Scoriels L; González A Lupus; 2015 May; 24(6):558-68. PubMed ID: 25318968 [TBL] [Abstract][Full Text] [Related]
26. Cognitive impairment in patients with systemic lupus erythematosus. Hanly JG; Fisk JD; Sherwood G; Jones E; Jones JV; Eastwood B J Rheumatol; 1992 Apr; 19(4):562-7. PubMed ID: 1593578 [TBL] [Abstract][Full Text] [Related]
27. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities. Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328 [TBL] [Abstract][Full Text] [Related]
28. Neuropsychological assessment in mixed connective tissue disease: comparison with systemic lupus erythematosus. Nowicka-Sauer K; Czuszynska Z; Majkowicz M; Smolenska Z; Jarmoszewicz K; Olesinska M; Siebert J Lupus; 2012 Aug; 21(9):927-33. PubMed ID: 22433916 [TBL] [Abstract][Full Text] [Related]
29. Neurocytotoxic antibodies in serum of patients with systemic lupus erythematosus. Bluestein HG Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3965-9. PubMed ID: 279013 [TBL] [Abstract][Full Text] [Related]
30. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Sanna G; Piga M; Terryberry JW; Peltz MT; Giagheddu S; Satta L; Ahmed A; Cauli A; Montaldo C; Passiu G; Peter JB; Shoenfeld Y; Mathieu A Lupus; 2000; 9(8):573-83. PubMed ID: 11035431 [TBL] [Abstract][Full Text] [Related]
31. White matter lesions and brain atrophy in systemic lupus erythematosus patients: correlation to cognitive dysfunction in a cohort of systemic lupus erythematosus patients using different definition models for neuropsychiatric systemic lupus erythematosus. Cannerfelt B; Nystedt J; Jönsen A; Lätt J; van Westen D; Lilja A; Bengtsson A; Nilsson P; Mårtensson J; Sundgren PC Lupus; 2018 Jun; 27(7):1140-1149. PubMed ID: 29523054 [TBL] [Abstract][Full Text] [Related]
32. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus. Schneebaum AB; Singleton JD; West SG; Blodgett JK; Allen LG; Cheronis JC; Kotzin BL Am J Med; 1991 Jan; 90(1):54-62. PubMed ID: 1986591 [TBL] [Abstract][Full Text] [Related]
33. Cognitive impairment in systemic lupus erythematosus: a follow-up study. Carlomagno S; Migliaresi S; Ambrosone L; Sannino M; Sanges G; Di Iorio G J Neurol; 2000 Apr; 247(4):273-9. PubMed ID: 10836619 [TBL] [Abstract][Full Text] [Related]
34. Prevalence of cognitive impairment in systemic lupus erythematosus. Carbotte RM; Denburg SD; Denburg JA J Nerv Ment Dis; 1986 Jun; 174(6):357-64. PubMed ID: 3711879 [TBL] [Abstract][Full Text] [Related]
35. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. McLaurin EY; Holliday SL; Williams P; Brey RL Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428 [TBL] [Abstract][Full Text] [Related]
36. Neuronal antibodies and cognitive function in systemic lupus erythematosus. Denburg JA; Carbotte RM; Denburg SD Neurology; 1987 Mar; 37(3):464-7. PubMed ID: 3822139 [TBL] [Abstract][Full Text] [Related]
37. Antibodies reactive with central nervous system antigens. Bluestein HG; Zvaifler NJ Hum Pathol; 1983 May; 14(5):424-8. PubMed ID: 6132871 [TBL] [Abstract][Full Text] [Related]
38. Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus. Denburg SD; Denburg JA Lupus; 2003; 12(12):883-90. PubMed ID: 14714906 [TBL] [Abstract][Full Text] [Related]
39. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. Mok CC; Lau CS; Wong RW J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248 [TBL] [Abstract][Full Text] [Related]
40. Lymphocyte destruction by antibody-dependent cellular cytotoxicity mediated in vitro by antibodies in serum from patients with systemic lupus erythematosus. Mahowald ML; Dalmasso AP Ann Rheum Dis; 1982 Dec; 41(6):593-8. PubMed ID: 7149796 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]